Tag: Covid-19

Letter to the Editor: Steroid Management in a Patient with Myasthenia Gravis Undergoing COVID-19 Vaccination

Letter to the Editor: Steroid Management in a Patient with Myasthenia Gravis Undergoing COVID-19 Vaccination

| July 1, 2022

Funding/financial disclosures. The authors have no conflict of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2022;19(7–9):8.   Dear Editor: We report the case of a 70-year-old patient affected by ocular myasthenia gravis (MG), diagnosed three years ago due to double vision […]

Continue Reading

Acute Thalamic Ischemic Stroke in an Older Patient Newly Vaccinated with COVID-19 Vaccine Based on Adenoviral Vectors

Acute Thalamic Ischemic Stroke in an Older Patient Newly Vaccinated with COVID-19 Vaccine Based on Adenoviral Vectors

| April 1, 2022

by Kelly Mesa-Gamarra, MD; Mario Pineda-Paternina, MD; Edgar Castillo, MD; Loida Camargo, MD, MSc; Alexander Pabón, MD; Jorge Herrera-Pino, MD, PhD; Nicole Caldichoury, MSc; Pascual A. Gargiulo, MD, PhD; Yuliana Flórez, MSc; and Norman López, PhD Drs. Mesa-Gamarra, Pineda-Paternina, and Pabón are physicians, neurology residents with Universidad del Sinú in Cartagena, Colombia. Dr. Castillo is Chief of […]

Continue Reading

Letter to the Editor: Beware of Neuroleptic Malignant Syndrome in COVID-19 Pandemic

Letter to the Editor: Beware of Neuroleptic Malignant Syndrome in COVID-19 Pandemic

| July 1, 2021

Dear Editor: I read with great interest the recent article by Buttar et al1 detailing fatal consequences of the chronic neuroleptic malignant syndrome (NMS) from the United States. The authors prescribed the challenges of treating psychiatric patients with the possibility of NMS. They also indicated that ethnic groups concerning metabolic enzyme polymorphisms for antipsychotics, such […]

Continue Reading

Blood–Brain Barrier: COVID-19, Pandemics, and Cytokine Norms

Blood–Brain Barrier: COVID-19, Pandemics, and Cytokine Norms

| January 1, 2021

by Atmaram Yarlagadda, MD; Samuel L. Preston, DO;  Rachel P. Jeyadhas, MD; Adam Edward Lang, PharmD;  Rasha Hammamieh, PhD; And Anita H. Clayton, MD Dr. Yarlagadda is the Installation Director of Psychological Health at McDonald Army Health Center in Fort Eustis, Virginia. Dr. Preston is with Uniformed Services University of Health Sciences in Bethesda, Maryland. […]

Continue Reading

Drug Development for Mental Illness: How Psychiatry Clinical Trial Sites are Meeting the Challenge of the COVID-19 Pandemic

Drug Development for Mental Illness: How Psychiatry Clinical Trial Sites are Meeting the Challenge of the COVID-19 Pandemic

| January 1, 2021

by Robert E. Litman, MD; Peter Sorantin, PhD; and Elia E. Acevedo-Diaz, MD Drs. Litman is with CBH Health, Georgetown University Medical School in Washington, DC. Dr. Sorantin is with Sorantin Outcomes, LLC, in Mountain Lakes, New Jersey. Dr. Acevedo-Diaz is with CBH Health and the National Institute of Mental Health (NIMH) in Bethesda, Maryland. […]

Continue Reading

Neurological Aspects of Corona Virus Infectious Disease 2019 (COVID-19)

Neurological Aspects of Corona Virus Infectious Disease 2019 (COVID-19)

| April 1, 2020

by Nitin Butala       Dr. Butala is a Neurologist and Neurophysiologist at Baptist Health in Jacksonville, Florida and an Assistant professor of Neurology at the Lake Erie College of Osteopathic Medicine in Bradenton, Florida FUNDING: No funding was provided. DISCLOSURES: The author has no conflicts of interest relevant to the content of this […]

Continue Reading